Alcon 

€67.36
210
-€0.46-0.68% Today

Statistics

Day High
67.76
Day Low
67.34
52W High
-
52W Low
-
Volume
254
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
0.44%
Dividend
0.3

Upcoming

Dividends

0.44%Dividend Yield
May 25
€0.3
May 24
€0.24
May 23
€0.21
May 22
€0.19
May 21
€0.09
10Y Growth
N/A
5Y Growth
26.64%
3Y Growth
11.52%
1Y Growth
N/A

Earnings

3MarExpected
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Next
0.69
0.74
0.79
0.84
Expected EPS
0.7878023244
Actual EPS
N/A

Financials

10.28%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
18.99BRevenue
1.95BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 2U3.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its subsidiary Janssen Pharmaceuticals, competes in the eye health market, particularly in areas like contact lenses and surgical products similar to Alcon's offerings.
Cooper Companies
COO
Mkt Cap13.9B
The Cooper Companies operate through CooperVision and CooperSurgical, offering products that directly compete with Alcon's contact lens and eye care solutions.
Bausch Health Companies
BHC
Mkt Cap2.62B
Bausch Health Companies, through its division Bausch + Lomb, is a direct competitor in the eye health sector, offering a wide range of products from contact lenses to surgical instruments.
Novartis
NVS
Mkt Cap237.61B
Novartis, the former parent company of Alcon, continues to compete in the eye care market through its pharmaceutical products that address conditions like dry eye, retinal issues, and glaucoma.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie, through its acquisition of Allergan, competes in the eye care market with products targeting conditions such as dry eye and glaucoma, directly competing with Alcon's portfolio.
Staar Surgical
STAA
Mkt Cap1.28B
STAAR Surgical specializes in ophthalmic products, particularly in implantable lenses for the eye, competing directly with Alcon's intraocular lenses and cataract surgery products.
Integra Lifesciences
IART
Mkt Cap935.48M
Integra LifeSciences, while broader in focus, competes with Alcon in the surgical instruments market, particularly in tools and devices used in ophthalmic surgery.
Eco Science Solutions
ESSI
Mkt Cap26,479
EssilorLuxottica is a leader in the design, manufacture, and distribution of ophthalmic lenses, frames, and sunglasses, competing with Alcon's vision care products.

About

Alcon, Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under the PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers under the TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands. The company was formerly known as Alcon Universal S.A. and changed the name to Alcon, Inc. in December 2001. Alcon, Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
Show more...
CEO
Employees
24389
Country
CH
ISIN
CH0432492467
WKN
000A2PDXE

Listings

0 Comments

Share your thoughts

FAQ

What is Alcon stock price today?
The current price of 2U3.F is €67.36 EUR — it has decreased by -0.68% in the past 24 hours. Watch Alcon stock price performance more closely on the chart.
What is Alcon stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Alcon stocks are traded under the ticker 2U3.F.
When is the next Alcon earnings date?
Alcon is going to release the next earnings report on March 03, 2026.
What were Alcon earnings last quarter?
2U3.F earnings for the last quarter are 0.68 EUR per share, whereas the estimation was 0.66 EUR resulting in a +2.82% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Alcon revenue for the last year?
Alcon revenue for the last year amounts to 18.99B EUR.
What is Alcon net income for the last year?
2U3.F net income for the last year is 1.95B EUR.
Does Alcon pay dividends?
Yes, 2U3.F dividends are paid annual. The last dividend per share was 0.3 EUR. As of today, Dividend Yield (FWD)% is 0.44%.
How many employees does Alcon have?
As of February 02, 2026, the company has 24,389 employees.
In which sector is Alcon located?
Alcon operates in the Health Care sector.
When did Alcon complete a stock split?
Alcon has not had any recent stock splits.